Emergency Agitation in T&A

Seoul National University

Status: Completed

Conditions: Healthy

Treatments: Drug: normal saline; Drug: remifentanil

Study type: Interventional

Funder types: Other

Identifiers

NCT01152476

T&A_EA

Details and patient eligibility

About

Sevoflurane has been used commonly in pediatric anesthesia since 1990. However, it has caused more emergency agitation (EA) that other inhalation agents and the incidence is up to 80%. Therefore, lower minimum alveolar concentration of sevoflurane will reduce the EA when it is used with remifentanil in pediatric general anesthesia.

Enrollment: 42 estimated patients

Sex: All

Ages: 2 to 6 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• American Society of Anesthesiologist physical status I or II
• 2-6 year-old children
• patients undergoing tonsillectomy and adenoidectomy

Exclusion criteria

• upper respiratory disease
• mental retardation

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

42 participants in 2 patient groups

group SR

Active Comparator group

Treatment:

Drug: remifentanil

group S

Active Comparator group

Treatment:

Drug: normal saline